课题基金 / 基金详情

Data and Safety Monitoring

Data and Safety Monitoring
数据和安全监控
批准号:
8250424
负责人:
JAMES A STEWART
金额:
$12.54万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2013-03-31

项目摘要

项目成果

JAMES A STEWART的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Data and Safety Monitoring System.(DSMS) of the UWCCC ensures that all clinical research being conducted under the auspices of the UWCCC is in compliance with federal requirements and most importantly that human subject safety is always optimized. The DSMS is assisted in its mission of safety and compliance by experienced UWCCC research staff, a Data and Safety Monitoring Committee (DSMC) composed of experienced clinical researchers, and the ongoing use of ONCORE database which allows more efficient tracking of protocols and protocol subjects. The DSMC reviews reports on quality assurance (internal audits, response reviews), protocol deviations and severe adverse events. The DSMC also provides data review, data abstraction and entry, forms monitoring and final report generation for studies developed and solely monitored by the UWCCC. The DSMC is chaired and co-chaired by James Stewart, Professor of Medicine, and KyungMann Kim, Professor of Biostatistics and Medical Informatics, each with > 20 years of clinical trials experience.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Data and Safety Monitoring
  • 批准号:
    7491903
  • 项目类别:
  • 资助金额:
    $11.44万
  • 财政年份:
    2007
  • 负责人:
    JAMES A STEWART
  • 依托单位:
PHASE II TRIAL OF TWO DOSE LEVELS OF CCI-779 IN EXTENSIVE-STAGE SCLC
  • 批准号:
    7204343
  • 项目类别:
  • 资助金额:
    $0.04万
  • 财政年份:
    2005
  • 负责人:
    JAMES A STEWART
  • 依托单位:
HIGH-DOSE IFN-ALPHA-2B VS CISPLATIN, VINBLASTINE, DTIC + IL-2 & IFN IN MELANOMA
  • 批准号:
    7204326
  • 项目类别:
  • 资助金额:
    $1.8万
  • 财政年份:
    2005
  • 负责人:
    JAMES A STEWART
  • 依托单位:
ZOSUQUIDAR TRIHYDROCHLORIDE IN NEWLY DIAGNOSED AML
  • 批准号:
    7204349
  • 项目类别:
  • 资助金额:
    $0.3万
  • 财政年份:
    2005
  • 负责人:
    JAMES A STEWART
  • 依托单位:
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data